Greg Verdine
Former Venture Partner at Third Rock Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Greg
515 people in our graph can introduce you to Greg.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Milenko Cicmil to introduce you to Greg
You →Milenko · together at Fogpharma (2017–2019) →Greg
Ask Jamie Chen to introduce you to Greg
You →Jamie · 2 people · together at Fogpharma →Greg
Ask Sam Okafor to introduce you to Greg
You →Sam · 9 people · together at Third Rock Ventures →Greg
Sign up to find every way you can get introduced to Greg
- Your email: the people you already email who know Greg
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Greg
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Greg Verdine is a Venture Partner at Andreessen Horowitz with experience across academic research, biotech company formation, drug development, and venture capital investment. His background spans basic and applied science, therapeutic discovery, and capital allocation in biotechnology and related sectors.
Experience
- Andreessen HorowitzVenture Partnercurrent2023 — presentAt large
- LifeMine TherapeuticsCo-Founder, President and CEO, CTO, Directorcurrent2016 — present30 Acorn Park Drive, Cambridge, MA 02140
- Harvard UniversityErving Professor of Chemistry, Harvard College Professor, Emerituscurrent2020 — presentCambridge, Massachusetts, United States
- Harvard UniversityErving Professor of Chemistry1989 — 2020
- WAVE Life Sciences Ltd.Founder, Founding ex-(President, CEO and CSO), Directorcurrent2009 — presentBoston, MA
- FogPharmaCo-Founder, Vice-Chair and Special Advisor2023 — 2024Cambridge, Massachusetts, United States
- FogPharmaCo-Founder, Chair, President and CEO, CSO2015 — 202330 Acorn Park Drive, Cambridge, Massachusetts
- WUXI Healthcare VenturesVenture Partner2016 — 2021Cambridge, Massachusetts
- Warp Drive Bio, Inc. (merged with Revolution Medicines, NASDAQ: RVMD)Co-founder, interim CSO and CEO, Board Director, SAB Chair2011 — 2017Cambridge, MA
- Third Rock VenturesVenture Partner2008 — 2015Boston, MA
- TPG BiotechVenture Partner2007 — 2008San Francisco Bay Area
- Apple Tree PartnersVenture Partner2002 — 2006New Yok, NY
Skills & more
+12 more
Start-upsOrganic ChemistryGeneticsClinical DevelopmentGenomicsBioinformaticsHigh Throughput ScreeningELISAPharmaceutical IndustryTechnology TransferImmunologyMedicinal ChemistryFrom Greg's professional profile.
Frequently asked questions
- Who is Greg Verdine?
- Greg Verdine is a Venture Partner at Andreessen Horowitz with experience across academic research, biotech company formation, drug development, and venture capital investment. His background spans basic and applied science, therapeutic discovery, and capital allocation in biotechnology and related sectors.
- What check size does Greg Verdine write?
- Greg Verdine typically writes checks of $100K – $5M.
- Where did Greg Verdine go to school?
- Greg Verdine studied at Columbia University (PhD, Chemistry); Massachusetts Institute of Technology (Postdoc, Molecular Biology).
Same school
Also attended Columbia University1,446
+ 1,440 more
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Shared employers
Also worked at LifeMine Therapeutics3
Also worked at WAVE Life Sciences Ltd.7
+ 1 more
Also worked at FogPharma8
+ 2 more
Also worked at Third Rock Ventures107
+ 101 more

































